Funding builds on FYR's neuro-oncology expertise and applies EV-based biomarkers to de-risk NuvOx's clinical development FYR brings deep expertise in identifying EV-based biomarkers in neuro-oncology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results